NASDAQ · Financial Statements

Sanara MedTech Inc. (SMTI) Revenue, Earnings & Financial Statements

$32.73 NASDAQ: SMTI Market Cap $300.55M

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Sanara MedTech Inc. most recently reported annual revenue of $103.0M, a net loss of $38.0M. Revenue grew at an average annual rate of 45.1% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Sanara MedTech Inc.: Revenue rose from $6.0M in 2016 to $103.0M in 2025, a change of +1616.7% over 9 years; net profit was positive in 0 of 10 reported years; operating margin moved from -4.9% to 8.9%, a shift of +13.8 percentage points; the most recent year shows a net loss of $38.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$6.0M$6.0M$6.0M$12.0M$16.0M$24.0M$46.0M$65.0M$87.0M$103.0M
Operating Expenses$6.0M$6.0M$6.0M$15.0M$21.0M$32.0M$58.0M$69.0M$93.0M$94.0M
Operating Profit$0$0−$1.0M−$3.0M−$5.0M−$7.0M−$13.0M−$4.0M−$7.0M$9.0M
Operating Margin-4.9%1.9%-8.6%-23.3%-32.3%-30.6%-27.3%-6.5%-7.8%8.9%
Other Income$0$0$0$0$1.0M−$1.0M−$1.0M$0−$3.0M−$10.0M
Interest$0$0$0$0$0$0$0$0$3.0M$7.0M
Depreciation$0$0$0$0$0$1.0M$2.0M$4.0M$5.0M$29.0M
Profit Before Tax$0$0−$1.0M−$3.0M−$4.0M−$8.0M−$14.0M−$4.0M−$10.0M$0
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%41.9%0.0%0.0%0.0%
Net Profit$0$0−$1.0M−$3.0M−$4.0M−$8.0M−$8.0M−$4.0M−$10.0M−$38.0M
EPS−$0.38$0.09−$0.28−$1.37−$0.76−$1.08−$1.00−$0.52−$1.14−$4.36

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$18.0M$19.0M$20.0M$22.0M$26.0M$23.0M$26.0M$26.0M$28.0M$28.0M$28.0M$28.0M
Operating Expenses$18.0M$20.0M$23.0M$24.0M$27.0M$23.0M$26.0M$23.0M$25.0M$25.0M$26.0M$28.0M
Operating Profit$0−$2.0M−$3.0M−$2.0M$0$1.0M$0$3.0M$3.0M$3.0M$2.0M$1.0M
Operating Margin-1.3%-8.3%-14.3%-8.9%-1.4%3.5%-0.1%11.3%10.5%9.5%6.3%2.6%
Interest$0$0$1.0M$1.0M$1.0M$1.0M$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M
Profit Before Tax$0−$2.0M−$4.0M−$3.0M−$2.0M−$1.0M−$2.0M$1.0M−$1.0M$0$0−$1.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit$0−$2.0M−$4.0M−$3.0M−$2.0M−$4.0M−$2.0M−$30.0M−$2.0M$0$0−$1.0M
EPS−$0.03−$0.21−$0.41−$0.34−$0.18−$0.41−$0.23−$3.52−$0.20$0.05−$0.05−$0.16

Over the 10 years reported for Sanara MedTech Inc., borrowings increased from $2.0M in 2016 to $48.0M in 2025, cash stood at $17.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.79 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$2.0M$2.0M$3.0M$11.0M$10.0M$36.0M$61.0M$74.0M$88.0M$73.0M
Current Assets$2.0M$2.0M$1.0M$9.0M$4.0M$25.0M$21.0M$19.0M$33.0M$34.0M
Cash$1.0M$0$1.0M$7.0M$0$19.0M$9.0M$5.0M$16.0M$17.0M
Inventory$0$1.0M$0$1.0M$1.0M$2.0M$4.0M$5.0M$3.0M$4.0M
Receivables$1.0M$1.0M$0$1.0M$2.0M$3.0M$7.0M$9.0M$14.0M$12.0M
Fixed Assets$0$0$0$1.0M$1.0M$2.0M$2.0M$3.0M$2.0M$3.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$2.0M$0$1.0M$5.0M$3.0M$3.0M$8.0M$15.0M
Other Assets$0$0$0$0$0$0$4.0M$4.0M$4.0M$4.0M
Total Liabilities$3.0M$2.0M$2.0M$5.0M$4.0M$6.0M$19.0M$29.0M$49.0M$67.0M
Current Liabilities$1.0M$2.0M$0$3.0M$4.0M$6.0M$13.0M$14.0M$15.0M$19.0M
Borrowings$2.0M$1.0M$2.0M$2.0M$0$0$1.0M$12.0M$32.0M$48.0M
Other Liabilities$1.0M$1.0M$0$3.0M$4.0M$6.0M$18.0M$17.0M$17.0M$19.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$0$0$1.0M$7.0M$6.0M$31.0M$42.0M$45.0M$39.0M$6.0M

For Sanara MedTech Inc., operating cash flow was positive in 1 of 10 reported years; free cash flow in the latest year was $2.0M; free cash flow was positive in 1 of 10 years; financing activities used $8.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$0$0$0−$2.0M−$4.0M−$5.0M−$6.0M−$3.0M$0$7.0M
Investing Cash Flow$0$0$0−$3.0M−$4.0M−$6.0M−$4.0M−$10.0M−$7.0M−$13.0M
Financing Cash Flow$0$0$0$10.0M$0−$1.0M−$1.0M−$1.0M−$2.0M−$8.0M
Net Cash Flow$1.0M$0$0$6.0M−$6.0M$18.0M−$10.0M−$4.0M$11.0M−$10.0M
Free Cash Flow$0$0$0−$4.0M−$6.0M−$6.0M−$6.0M−$4.0M$0$2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.76
EV / EBITDA44.87
FCF Yield2.45%
Quick Ratio2.03
Interest Coverage1.11
Return 1Y52.09%
Return 3Y-1.00%
Return 5Y-1.92%

Sanara MedTech Inc. (SMTI) financials — frequently asked questions

What is Sanara MedTech Inc.'s annual revenue?

Sanara MedTech Inc. (SMTI) reported annual revenue of $103.0M in its most recent fiscal year.

What is Sanara MedTech Inc.'s net profit?

Sanara MedTech Inc. (SMTI) reported a net loss of $38.0M in its most recent fiscal year.

What is SMTI EV/EBITDA?

Sanara MedTech Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 44.87.

Revenue and earnings of other Medical - Instruments & Supplies stocks

BDX revenue $19.5BMDLN stockWST revenue $3.1BSOLV revenue $8.3BBAX revenue $11.2BCOO revenue $4.1BRGEN revenue $738.0MAVTR revenue $6.6BATR revenue $3.8BBLCO revenue $5.1BAll Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
SMTI Overview SMTI Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.